Meenakshi Shukla summarises a systematic review exploring the trajectory of blood pressure, body mass index, cholesterol and incident dementia.
[read the full story...]Cardiovascular risk in severe mental illness: is there a right intervention?
A group of Masters Students from the University of Glasgow Global Mental Health MSc write about the Primrose trial, which looked at the clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk in severe mental illness.
[read the full story...]Antipsychotics and metabolic function in people with schizophrenia
Peter Haddad and Sami Ouanes review a network meta-analysis of the impact of antipsychotic drugs on metabolic function in people with schizophrenia.
[read the full story...]Statins for dementia prevention: well-tolerated, but Cochrane highlight lack of evidence
Rosalyn Nelson summarises a recently updated Cochrane systematic review of statins for dementia prevention, which finds no evidence to support their use.
[read the full story...]